Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis
NCT02404636 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2017-04-10
Summary
ADDUP is an observational study of patients with alcoholic hepatitis. A structured interview is used to quantitatively estimate:
1. Alcohol use
2. Dietary intake
3. Drug use (legal and illegal)
in the weeks preceding onset of acute alcoholic hepatitis. After interview patients are followed up for 12 months with regard to response to therapy and survival.
The study is intended to explore potential precipitants of alcoholic hepatitis.
Conditions
- Hepatitis, Alcoholic
Interventions
- OTHER
-
Interview
Brief structured interview
Sponsors & Collaborators
-
University Hospital Birmingham
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Buprenorphine Maintenance for Opioid Addicts - 3
NCT00000204 ·Status: COMPLETED ·Phase: PHASE2
-
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
NCT00023283 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
NCT00244374 ·Status: COMPLETED ·Phase: NA
-
Drug Interaction & Methadone & Buprenorphine
NCT02045693 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
NCT00555425 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention Interventions for Opioid Misuse
NCT04550715 ·Status: COMPLETED ·Phase: NA
-
UCLA-Amity Parolee Health Promotion Study
NCT01844414 ·Status: COMPLETED ·Phase: NA
-
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059 ·Status: COMPLETED ·Phase: NA
-
Emergency Department-Initiated Buprenorphine Validation Network Trial
NCT04225598 ·Status: COMPLETED ·Phase: PHASE2
-
A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence
NCT02718352 ·Status: COMPLETED
-
Buprenorphine and Integrated HIV Care
NCT00317460 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
NCT00486330 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.
NCT06231849 ·Status: NOT_YET_RECRUITING
-
Gradual Vs. Rapid Buprenorphine Detoxification - 2
NCT00000220 ·Status: COMPLETED ·Phase: PHASE1
-
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
NCT00249574 ·Status: COMPLETED ·Phase: NA
-
Drug Abuse Among Elective Surgeries: an Observational Study.
NCT05123521 ·Status: COMPLETED
-
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
NCT06827288 ·Status: RECRUITING ·Phase: NA
-
Yoga for Pain and Opioid Dependence
NCT01590251 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hair Testing to Assess Consumption of Illicit Psychotropic Agents and Alcohol by Patients Treated With High-dose Buprenorphine and Methadone. Search for a Pharmacogenetic Contribution to Low Efficacy of Substitution Medications
NCT01285856 ·Status: UNKNOWN ·Phase: NA
-
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
NCT01096550 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
NCT00000231 ·Status: COMPLETED ·Phase: PHASE2
-
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
NCT03221309 ·Status: COMPLETED
-
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
NCT04480554 ·Status: TERMINATED ·Phase: PHASE2
-
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
NCT07342504 ·Status: RECRUITING ·Phase: NA
-
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
NCT06323824 ·Status: RECRUITING ·Phase: PHASE4